Z Li Selected Research

9-hydroxyellipticine

2/2000

Diverse effects of 9-hydroxyellipticine on the chemosensitivity of human pancreatic cancer cells harboring p53 mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Z Li Research Topics

Disease

144	Neoplasms (Cancer) 07/2022 - 01/2000
49	Infections 06/2022 - 04/2000
37	Neoplasm Metastasis (Metastasis) 06/2021 - 09/2000
32	Inflammation (Inflammations) 01/2022 - 06/2000
23	Breast Neoplasms (Breast Cancer) 09/2020 - 11/2000
23	Carcinoma (Carcinomatosis) 01/2020 - 04/2000
21	Body Weight (Weight, Body) 08/2022 - 04/2000
18	Wounds and Injuries (Trauma) 04/2022 - 10/2000
17	Carcinogenesis 10/2017 - 02/2000
16	Pain (Aches) 01/2022 - 01/2006
15	Necrosis 01/2022 - 11/2001
15	Type 2 Diabetes Mellitus (MODY) 07/2021 - 11/2000
14	Stomach Neoplasms (Stomach Cancer) 04/2020 - 04/2000
13	Hemorrhage 01/2022 - 08/2000
13	Lung Neoplasms (Lung Cancer) 07/2017 - 01/2000
12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2020 - 03/2000
11	Rheumatoid Arthritis 03/2020 - 04/2000
11	Osteoporosis 01/2019 - 12/2000
11	Hepatocellular Carcinoma (Hepatoma) 02/2018 - 01/2000
10	Pathologic Constriction (Stenosis) 03/2022 - 06/2000
10	Fibrosis (Cirrhosis) 03/2022 - 03/2001
10	Lymphatic Metastasis 10/2021 - 01/2000
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2021 - 01/2000
10	Leukemia 03/2020 - 05/2000
10	Insulin Resistance 09/2018 - 05/2000
9	Stroke (Strokes) 10/2020 - 05/2011
8	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 02/2000
8	Colonic Neoplasms (Colon Cancer) 07/2021 - 01/2009
8	Hypersensitivity (Allergy) 12/2019 - 01/2006
8	Glioma (Gliomas) 03/2019 - 09/2014
8	Adenocarcinoma 01/2019 - 12/2000
7	Diabetes Mellitus 07/2022 - 06/2000
7	Hypertension (High Blood Pressure) 01/2022 - 03/2001
7	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 04/2000
7	Esophageal Squamous Cell Carcinoma 01/2022 - 09/2000
7	Hypoxia (Hypoxemia) 01/2021 - 12/2008
7	Lymphoma (Lymphomas) 01/2017 - 09/2000
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2015 - 01/2000
6	Burns 04/2022 - 10/2000
6	Proteinuria 01/2022 - 01/2007
6	Atherosclerosis 10/2021 - 07/2001
6	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 09/2011
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 08/2000
6	Hepatitis B 02/2018 - 01/2000
6	Multiple Myeloma 01/2018 - 02/2000
6	Obesity 05/2017 - 01/2007
6	Osteoarthritis 01/2017 - 01/2013
6	Schizophrenia (Dementia Praecox) 01/2017 - 10/2007
5	Chronic Obstructive Pulmonary Disease (COPD) 04/2022 - 11/2001
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2021 - 10/2007

Drug/Important Bio-Agent (IBA)

65	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2000
27	Messenger RNA (mRNA)IBA 07/2021 - 01/2000
21	DNA (Deoxyribonucleic Acid)IBA 02/2018 - 01/2000
19	AntigensIBA 03/2022 - 03/2000
19	CytokinesIBA 09/2021 - 10/2000
18	Pharmaceutical PreparationsIBA 01/2018 - 02/2000
16	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2000
16	EnzymesIBA 07/2021 - 01/2000
16	Biological ProductsIBA 01/2021 - 12/2000
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2007
14	Insulin (Novolin)FDA Link 09/2018 - 01/2000
13	VaccinesIBA 12/2021 - 08/2000
12	Glucose (Dextrose)FDA LinkGeneric 07/2019 - 12/2000
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2019 - 09/2000
12	Peptides (Polypeptides)IBA 09/2016 - 12/2001
11	AntibodiesIBA 12/2020 - 01/2000
10	Small Interfering RNA (siRNA)IBA 12/2018 - 03/2010
9	Phosphotransferases (Kinase)IBA 10/2021 - 10/2003
9	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 03/2001
9	ImmunosorbentsIBA 05/2020 - 07/2007
9	MicroRNAs (MicroRNA)IBA 02/2019 - 01/2014
9	LigandsIBA 01/2019 - 03/2006
8	Interleukin-6 (Interleukin 6)IBA 10/2020 - 10/2000
8	CollagenIBA 01/2020 - 03/2004
7	RNA (Ribonucleic Acid)IBA 10/2021 - 09/2000
7	Long Noncoding RNAIBA 10/2020 - 06/2014
6	LipidsIBA 08/2022 - 04/2001
6	InterleukinsIBA 01/2022 - 11/2001
6	AntioxidantsIBA 12/2021 - 05/2011
6	SolutionsIBA 11/2021 - 04/2000
6	CreatinineIBA 10/2021 - 02/2015
6	Blood Glucose (Blood Sugar)IBA 10/2021 - 11/2000
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2001
6	Tyrosine Kinase InhibitorsIBA 11/2019 - 05/2016
6	DesminIBA 03/2019 - 08/2001
6	AutoantibodiesIBA 10/2017 - 04/2000
5	CateninsIBA 01/2022 - 09/2011
5	Interleukin-17 (Interleukin 17)IBA 10/2021 - 11/2011
5	C-Reactive ProteinIBA 05/2021 - 04/2000
5	Mitogen-Activated Protein KinasesIBA 03/2021 - 08/2004

Therapy/Procedure

79	Therapeutics 01/2022 - 01/2000
23	Drug Therapy (Chemotherapy) 03/2022 - 06/2000
12	Transplantation 04/2022 - 05/2000
12	Radiotherapy 06/2021 - 04/2001
9	Perforator Flap 04/2022 - 12/2016
8	Stents 02/2019 - 01/2006
7	Neoadjuvant Therapy 03/2022 - 08/2001
7	Aftercare (After-Treatment) 09/2018 - 06/2000
6	Hematopoietic Stem Cell Transplantation 01/2022 - 07/2013
6	Length of Stay 04/2020 - 03/2001